Colleen Jonsson, PhD, professor and Endowed Van Vleet Chair of Excellence in Virology at the University of Tennessee Health Science Center (UTHSC), has been awarded over $21 million in funding to establish a Center of Excellence for Encephalitic Alphavirus Therapeutics program aimed at advancing the discovery and development of potent antiviral drug candidates targeting several… Read More
The University of Tennessee Health Science Center’s (UTHSC) Junling Wang, PhD, professor in the Department of Clinical Pharmacy and Translational Science, has been awarded over $1.4 million from the National Institutes of Health (NIH) to further her research on the equity and economic effects of medication management therapy programs. Her project titled, “Equity and Economic Effects… Read More
Marko Radic, PhD, associate professor of Microbiology, Immunology, and Biochemistry in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has published a paper in Science Translational Medicine that explores a novel treatment option for Systemic lupus erythematosus (SLE) using a targeted immunotherapy approach. According to the Centers for Disease Control… Read More
Ramesh Narayanan, PhD, associate professor in the Department of Medicine-Hematology and adjunct associate professor in the Departments of Urology and Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2 million from the National Institutes of Health (NIH) to develop novel tools and next generation drugs designed to treat… Read More
Glaucoma is the leading cause of irreversible blindness in the world and affects more than three million people in the United States each year. Currently, there is no cure for this crippling disease, only the option to treat one’s symptoms. Monica M. Jablonski, PhD, professor in the Department of Ophthalmology in the College of Medicine… Read More
